EKF Diagnostics Holdings plc (EKF) Q4 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, and welcome to the EKF Diagnostic Holdings Premier Results investor presentation. Throughout today's recorded presentation, investors will be in listen-only mode. Questions are encouraged and can be submitted at any time using the Q&A tab situated on the right-hand corner of your screen. Please simply type in your questions at any time and press send. The company may not be in a position to answer every question received during the meeting itself. However, the company can review all questions submitted today, and we'll publish those responses where it's appropriate to do so. Before we begin, we'd like to submit the following poll, and I'd now like to hand over to Executive Chair, Julian Baines. Good afternoon. Good afternoon, everyone. Thank you very much for joining the EKF Diagnostics final results presentation. I'm joined here today by our new CEO, Gavin Jones, and by our CFO, Stephen Young. and I will start the presentation straight away. So in terms of the business, I think that the business has performed really well against what the board tasked us to do over the last year. We've had revenues of £50.2 million and that reflects the removal of any legacy products we had in our portfolio, which we've done very successfully. And this is demonstrated by the fact that our gross margin now has increased to 48% from 45% last year. showing that this move was the correct move for us. In addition, our adjusted EBITDA has increased to 11.3 million, which is slightly ahead of what we forecast in January when we forecast 11 million. So 11.3 million adjusted EBITDA. which shows a 9.9 million growth in adjusted EBITDA over the past year, again reflecting lower revenues but higher margin and EBITDA. Profit before tax of 6.3 million against 2.4 last year. C...